In vitro activity of inexpensive topical alternatives against Candida spp. isolated from the oral cavity of HIV-infected patients

International Journal of Antimicrobial Agents

Volumn 31, Issue 3, 2008, Pages 272-276

  Traboulsi, Rana S ^a,b   Mukherjee, Pranab K ^a,b   Ghannoum, Mahmoud A ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

AIDS; Antifungal agents; Candida; Gentian violet; HIV

Indexed keywords

CHLORHEXIDINE; CRYSTAL VIOLET; FLUCONAZOLE; POVIDONE IODINE; TEA TREE OIL;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; THRUSH;

ANTIFUNGAL AGENTS; CANDIDA; CANDIDIASIS, ORAL; DRUG INTERACTIONS; HIV INFECTIONS; HUMANS; MICROBIAL SENSITIVITY TESTS; MICROBIAL VIABILITY; MOUTH;

EID: 39149135826     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2007.11.008     Document Type: Article

References (19)

1. Reichart P.A. Oral manifestations in HIV infection: fungal and bacterial infections, Kaposi's sarcoma. Med Microbiol Immunol 192 (2003) 165-169
2. Van Meter F., Gallo J.W., Garcia-Rojas G., Tan M.M., and Silverman Jr. S. A study of oral candidiasis in HIV-positive patients. J Dent Hyg 68 (1994) 30-34
3. Benson C.A., Kaplan J.E., Masur H., Pau A., and Holmes K.K. CDC; National Institutes of Health; Infectious Diseases Society of America. Treating opportunistic infections among HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association/Infectious Diseases Society of America. MMWR Recomm Rep 53 (2004) 1-112
4. Wertheimer A.I., Santella T.M., and Lauver H.J. Successful public/private donation programs: a review of the Diflucan Partnership Program in South Africa. J Int Assoc Physicians AIDS Care (Chic Ill) 3 (2004) 74-9, 84-85
5. Fichtenbaum C.J., and Powderly W.G. Refractory mucosal candidiasis in patients with human immunodeficiency virus infection. Clin Infect Dis 26 (1998) 556-565
6. Willocks L., Leen C.L., Brettle R.P., Urquhart D., Russell T.B., and Milne L.J. Fluconazole resistance in AIDS patients. J Antimicrob Chemother 28 (1991) 937-939
7. Ruhnke M., Eigler A., Tennagen I., Geiseler B., Engelmann E., and Trautmann M. Emergence of fluconazole-resistant strains of Candida albicans in patients with recurrent oropharyngeal candidosis and human immunodeficiency virus infection. J Clin Microbiol 32 (1994) 2092-2098
8. Nyst M.J., Perriens J.H., Kimputu L., Lumbila M., Nelson A.M., and Piot P. Gentian violet, ketoconazole and nystatin in oropharyngeal and esophageal candidiasis in Zairian AIDS patients. Ann Soc Belg Med Trop 72 (1992) 45-52
9. Jandourek A., Vaishampayan J.K., and Vazquez J.A. Efficacy of melaleuca oral solution for the treatment of fluconazole refractory oral candidiasis in AIDS patients. AIDS 12 (1998) 1033-1037
10. Barasch A., Safford M.M., Dapkute-Marcus I., and Fine D.H. Efficacy of chlorhexidine gluconate rinse for treatment and prevention of oral candidiasis in HIV-infected children: a pilot study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 97 (2004) 204-207
11. Clinical and Laboratory Standards Institute. Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard, 2nd ed. Document M27-A2. Wayne, PA: CLSI; 2002.
12. Canton E., Peman J., Viudes A., Quindos G., Gobernado M., and Espinel-Ingroff A. Minimum fungicidal concentrations of amphotericin B for bloodstream Candida species. Diagn Microbiol Infect Dis 45 (2003) 203-206
13. Mukherjee P.K., Sheehan D.J., Hitchcock C.A., and Ghannoum M.A. Combination treatment of invasive fungal infections. Clin Microbiol Rev 18 (2005) 163-194
14. Docampo R., and Moreno S.N. The metabolism and mode of action of gentian violet. Drug Metab Rev 22 (1990) 161-178
15. Tobgi R.S., Samaranayake L.P., and Macfarlane T.W. Adhesion of Candida albicans to buccal epithelial cells exposed to chlorhexidine gluconate. J Med Vet Mycol 25 (1987) 335-338
16. Mondello F., De Bernardis F., Girolamo A., Salvatore G., and Cassone A. In vitro and in vivo activity of tea tree oil against azole-susceptible and -resistant human pathogenic yeasts. J Antimicrob Chemother 51 (2003) 1223-1229
17. Hoang T., Jorgensen M.G., Keim R.G., Pattison A.M., and Slots J. Povidone-iodine as a periodontal pocket disinfectant. J Periodontal Res 38 (2003) 311-317
18. Simon C., and Tabrizi S.A. On the in vitro sensitivity of Candida albicans to nystatin, trichomycin, amphotericin B and gentian violet. Med Welt 37 (1967) 2164-2168 [in German]
19. Ramirez L.E., Lages-Silva E., Pianetti G.M., Rabelo R.M., Bordin J.O., and Moraes-Souza H. Prevention of transfusion-associated Chagas' disease by sterilization of Trypanosoma cruzi-infected blood with gentian violet, ascorbic acid, and light. Transfusion 35 (1995) 226-230